EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis
| Autor: | Ologunowa, A, Caffrey, AR, Kogut, S |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S133-S133 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect